|ZFIN ID: ZDB-PUB-110921-51|
A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling
Saydmohammed, M., Vollmer, L.L., Onuoha, E.O., Vogt, A., and Tsang, M.
|Source:||Birth defects research. Part C, Embryo today : reviews 93(3): 281-287 (Journal)|
|Registered Authors:||Tsang, Michael|
|Keywords:||transgenic zebrafish, small molecule, FGF modulators, high-content analysis|
|PubMed:||21932436 Full text @ Birth Defects Res. C Embryo Today|
Saydmohammed, M., Vollmer, L.L., Onuoha, E.O., Vogt, A., and Tsang, M. (2011) A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling. Birth defects research. Part C, Embryo today : reviews. 93(3):281-287.
ABSTRACTZebrafish have become an invaluable vertebrate animal model to interrogate small molecule libraries for modulators of complex biological pathways and phenotypes. We have recently described the implementation of a quantitative, high-content imaging assay in multi-well plates to analyze the effects of small molecules on Fibroblast Growth Factor (FGF) signaling in vivo. Here we have evaluated the capability of the assay to identify compounds that hyperactivate FGF signaling from a test cassette of agents with known biological activities. Using a transgenic zebrafish reporter line for FGF activity, we screened 1040 compounds from an annotated library of known bioactive agents, including FDA-approved drugs. The assay identified two molecules, 8-hydroxyquinoline sulfate and pyrithione zinc, that enhanced FGF signaling in specific areas of the brain. Subsequent studies revealed that both compounds specifically expanded FGF target gene expression. Furthermore, treatment of early stage embryos with either compound resulted in dorsalized phenotypes characteristic of hyperactivation of FGF signaling in early development. Documented activities for both agents included activation of extracellular signal-related kinase (ERK), consistent with FGF hyperactivation. To conclude, we demonstrate the power of automated quantitative high-content imaging to identify small molecule modulators of FGF.